nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—Irinotecan—colon cancer	0.12	0.198	CbGbCtD
Estropipate—ALB—Fluorouracil—colon cancer	0.116	0.19	CbGbCtD
Estropipate—CYP2C9—Capecitabine—colon cancer	0.105	0.173	CbGbCtD
Estropipate—CYP1A2—Fluorouracil—colon cancer	0.0691	0.114	CbGbCtD
Estropipate—ALB—Methotrexate—colon cancer	0.0637	0.105	CbGbCtD
Estropipate—CYP2C9—Fluorouracil—colon cancer	0.0623	0.103	CbGbCtD
Estropipate—CYP3A4—Irinotecan—colon cancer	0.0377	0.0622	CbGbCtD
Estropipate—CYP3A4—Vincristine—colon cancer	0.033	0.0544	CbGbCtD
Estropipate—ALB—gall bladder—colon cancer	0.0041	0.0729	CbGeAlD
Estropipate—ESR1—blood vessel—colon cancer	0.00372	0.0661	CbGeAlD
Estropipate—ESR2—epithelium—colon cancer	0.00264	0.047	CbGeAlD
Estropipate—ESR2—smooth muscle tissue—colon cancer	0.00255	0.0453	CbGeAlD
Estropipate—ESR2—renal system—colon cancer	0.00245	0.0436	CbGeAlD
Estropipate—ESR1—embryo—colon cancer	0.00222	0.0394	CbGeAlD
Estropipate—SLC22A1—renal system—colon cancer	0.00206	0.0365	CbGeAlD
Estropipate—ESR2—lymphoid tissue—colon cancer	0.00204	0.0362	CbGeAlD
Estropipate—ESR2—digestive system—colon cancer	0.00201	0.0357	CbGeAlD
Estropipate—ESR1—epithelium—colon cancer	0.00181	0.0322	CbGeAlD
Estropipate—SHBG—bone marrow—colon cancer	0.0018	0.032	CbGeAlD
Estropipate—ESR2—vagina—colon cancer	0.00178	0.0316	CbGeAlD
Estropipate—ESR1—smooth muscle tissue—colon cancer	0.00174	0.031	CbGeAlD
Estropipate—SHBG—vagina—colon cancer	0.00173	0.0307	CbGeAlD
Estropipate—ESR1—renal system—colon cancer	0.00168	0.0298	CbGeAlD
Estropipate—ESR2—liver—colon cancer	0.0015	0.0266	CbGeAlD
Estropipate—SLC22A1—vagina—colon cancer	0.00149	0.0265	CbGeAlD
Estropipate—SHBG—liver—colon cancer	0.00146	0.0259	CbGeAlD
Estropipate—ESR1—lymphoid tissue—colon cancer	0.00139	0.0248	CbGeAlD
Estropipate—ESR1—digestive system—colon cancer	0.00138	0.0245	CbGeAlD
Estropipate—CYP1A2—renal system—colon cancer	0.00129	0.023	CbGeAlD
Estropipate—SLC22A1—liver—colon cancer	0.00126	0.0223	CbGeAlD
Estropipate—Estriol—ABCB1—colon cancer	0.00122	0.264	CrCbGaD
Estropipate—ESR1—vagina—colon cancer	0.00122	0.0216	CbGeAlD
Estropipate—ALB—liver—colon cancer	0.0012	0.0214	CbGeAlD
Estropipate—ESR2—lymph node—colon cancer	0.00115	0.0204	CbGeAlD
Estropipate—Estramustine—ABCB1—colon cancer	0.00113	0.245	CrCbGaD
Estropipate—CYP1A2—digestive system—colon cancer	0.00106	0.0189	CbGeAlD
Estropipate—ESR1—liver—colon cancer	0.00103	0.0182	CbGeAlD
Estropipate—Acute coronary syndrome—Vincristine—colon cancer	0.00103	0.00429	CcSEcCtD
Estropipate—Myocardial infarction—Vincristine—colon cancer	0.00102	0.00426	CcSEcCtD
Estropipate—Neuropathy peripheral—Vincristine—colon cancer	0.00102	0.00426	CcSEcCtD
Estropipate—Thrombophlebitis—Capecitabine—colon cancer	0.00102	0.00425	CcSEcCtD
Estropipate—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00101	0.00423	CcSEcCtD
Estropipate—CYP2C9—digestive system—colon cancer	0.00101	0.0179	CbGeAlD
Estropipate—Hepatic function abnormal—Capecitabine—colon cancer	0.00101	0.00421	CcSEcCtD
Estropipate—Bone disorder—Methotrexate—colon cancer	0.000999	0.00418	CcSEcCtD
Estropipate—Acute coronary syndrome—Irinotecan—colon cancer	0.000999	0.00417	CcSEcCtD
Estropipate—Myocardial infarction—Irinotecan—colon cancer	0.000993	0.00415	CcSEcCtD
Estropipate—Infestation—Fluorouracil—colon cancer	0.000971	0.00406	CcSEcCtD
Estropipate—Infestation NOS—Fluorouracil—colon cancer	0.000971	0.00406	CcSEcCtD
Estropipate—Acute coronary syndrome—Fluorouracil—colon cancer	0.000957	0.004	CcSEcCtD
Estropipate—Myocardial infarction—Fluorouracil—colon cancer	0.000951	0.00398	CcSEcCtD
Estropipate—Neuropathy peripheral—Fluorouracil—colon cancer	0.000951	0.00398	CcSEcCtD
Estropipate—CYP3A4—renal system—colon cancer	0.000937	0.0166	CbGeAlD
Estropipate—Inflammation—Methotrexate—colon cancer	0.000931	0.00389	CcSEcCtD
Estropipate—ALB—lymph node—colon cancer	0.000922	0.0164	CbGeAlD
Estropipate—Dermatitis bullous—Capecitabine—colon cancer	0.000921	0.00385	CcSEcCtD
Estropipate—Purpura—Capecitabine—colon cancer	0.000913	0.00382	CcSEcCtD
Estropipate—Rhinitis—Irinotecan—colon cancer	0.000912	0.00381	CcSEcCtD
Estropipate—Sinusitis—Fluorouracil—colon cancer	0.000911	0.0038	CcSEcCtD
Estropipate—Pulmonary embolism—Methotrexate—colon cancer	0.000903	0.00377	CcSEcCtD
Estropipate—Vaginal inflammation—Methotrexate—colon cancer	0.000903	0.00377	CcSEcCtD
Estropipate—Cerebrovascular accident—Capecitabine—colon cancer	0.000898	0.00375	CcSEcCtD
Estropipate—Cystitis noninfective—Methotrexate—colon cancer	0.000882	0.00368	CcSEcCtD
Estropipate—Pain in extremity—Capecitabine—colon cancer	0.00088	0.00368	CcSEcCtD
Estropipate—Visual impairment—Irinotecan—colon cancer	0.000877	0.00366	CcSEcCtD
Estropipate—Rhinitis—Fluorouracil—colon cancer	0.000874	0.00365	CcSEcCtD
Estropipate—Cystitis—Methotrexate—colon cancer	0.000872	0.00364	CcSEcCtD
Estropipate—Cardiac disorder—Vincristine—colon cancer	0.000867	0.00362	CcSEcCtD
Estropipate—Migraine—Capecitabine—colon cancer	0.000866	0.00362	CcSEcCtD
Estropipate—Pharyngitis—Fluorouracil—colon cancer	0.000865	0.00361	CcSEcCtD
Estropipate—Vaginal infection—Methotrexate—colon cancer	0.000852	0.00356	CcSEcCtD
Estropipate—Angiopathy—Vincristine—colon cancer	0.000848	0.00354	CcSEcCtD
Estropipate—Cardiac disorder—Irinotecan—colon cancer	0.000844	0.00353	CcSEcCtD
Estropipate—Mediastinal disorder—Vincristine—colon cancer	0.000842	0.00352	CcSEcCtD
Estropipate—Irritability—Capecitabine—colon cancer	0.00084	0.00351	CcSEcCtD
Estropipate—Mood swings—Capecitabine—colon cancer	0.000834	0.00348	CcSEcCtD
Estropipate—Alopecia—Vincristine—colon cancer	0.000826	0.00345	CcSEcCtD
Estropipate—Angiopathy—Irinotecan—colon cancer	0.000825	0.00345	CcSEcCtD
Estropipate—Immune system disorder—Irinotecan—colon cancer	0.000822	0.00343	CcSEcCtD
Estropipate—Mediastinal disorder—Irinotecan—colon cancer	0.00082	0.00343	CcSEcCtD
Estropipate—Mental disorder—Vincristine—colon cancer	0.000818	0.00342	CcSEcCtD
Estropipate—Bladder pain—Methotrexate—colon cancer	0.000816	0.00341	CcSEcCtD
Estropipate—Neoplasm—Methotrexate—colon cancer	0.000816	0.00341	CcSEcCtD
Estropipate—Alopecia—Irinotecan—colon cancer	0.000804	0.00336	CcSEcCtD
Estropipate—Breast disorder—Capecitabine—colon cancer	0.000795	0.00332	CcSEcCtD
Estropipate—CYP1A2—liver—colon cancer	0.000791	0.0141	CbGeAlD
Estropipate—ESR1—lymph node—colon cancer	0.000787	0.014	CbGeAlD
Estropipate—Back pain—Vincristine—colon cancer	0.000787	0.00329	CcSEcCtD
Estropipate—Flatulence—Irinotecan—colon cancer	0.00078	0.00326	CcSEcCtD
Estropipate—Alopecia—Fluorouracil—colon cancer	0.00077	0.00322	CcSEcCtD
Estropipate—CYP3A4—digestive system—colon cancer	0.000769	0.0137	CbGeAlD
Estropipate—Back pain—Irinotecan—colon cancer	0.000766	0.0032	CcSEcCtD
Estropipate—Abdominal distension—Capecitabine—colon cancer	0.000766	0.0032	CcSEcCtD
Estropipate—Muscle spasms—Irinotecan—colon cancer	0.000761	0.00318	CcSEcCtD
Estropipate—Influenza—Capecitabine—colon cancer	0.000761	0.00318	CcSEcCtD
Estropipate—Asthma—Capecitabine—colon cancer	0.000761	0.00318	CcSEcCtD
Estropipate—Erythema—Fluorouracil—colon cancer	0.000759	0.00317	CcSEcCtD
Estropipate—Thrombophlebitis—Methotrexate—colon cancer	0.000757	0.00316	CcSEcCtD
Estropipate—CYP2C9—liver—colon cancer	0.000751	0.0133	CbGeAlD
Estropipate—Vertigo—Vincristine—colon cancer	0.000731	0.00305	CcSEcCtD
Estropipate—Abdominal discomfort—Capecitabine—colon cancer	0.000729	0.00305	CcSEcCtD
Estropipate—Vertigo—Irinotecan—colon cancer	0.000712	0.00297	CcSEcCtD
Estropipate—Dysuria—Capecitabine—colon cancer	0.000711	0.00297	CcSEcCtD
Estropipate—Upper respiratory tract infection—Capecitabine—colon cancer	0.000707	0.00295	CcSEcCtD
Estropipate—Myalgia—Vincristine—colon cancer	0.000692	0.00289	CcSEcCtD
Estropipate—Weight increased—Capecitabine—colon cancer	0.000692	0.00289	CcSEcCtD
Estropipate—Visual disturbance—Methotrexate—colon cancer	0.000691	0.00289	CcSEcCtD
Estropipate—Cough—Irinotecan—colon cancer	0.000691	0.00289	CcSEcCtD
Estropipate—Hyperglycaemia—Capecitabine—colon cancer	0.000686	0.00287	CcSEcCtD
Estropipate—Infestation—Capecitabine—colon cancer	0.000678	0.00283	CcSEcCtD
Estropipate—Infestation NOS—Capecitabine—colon cancer	0.000678	0.00283	CcSEcCtD
Estropipate—Anaphylactoid reaction—Methotrexate—colon cancer	0.000677	0.00283	CcSEcCtD
Estropipate—Depression—Capecitabine—colon cancer	0.000676	0.00283	CcSEcCtD
Estropipate—Acute coronary syndrome—Capecitabine—colon cancer	0.000669	0.00279	CcSEcCtD
Estropipate—Cerebrovascular accident—Methotrexate—colon cancer	0.000669	0.00279	CcSEcCtD
Estropipate—Ethinyl Estradiol—ABCB1—colon cancer	0.000666	0.144	CrCbGaD
Estropipate—Myocardial infarction—Capecitabine—colon cancer	0.000665	0.00278	CcSEcCtD
Estropipate—Neuropathy peripheral—Capecitabine—colon cancer	0.000665	0.00278	CcSEcCtD
Estropipate—Anaphylactic shock—Vincristine—colon cancer	0.000664	0.00277	CcSEcCtD
Estropipate—Oedema—Vincristine—colon cancer	0.000664	0.00277	CcSEcCtD
Estropipate—Infection—Vincristine—colon cancer	0.000659	0.00275	CcSEcCtD
Estropipate—Nervous system disorder—Vincristine—colon cancer	0.000651	0.00272	CcSEcCtD
Estropipate—Oedema—Irinotecan—colon cancer	0.000646	0.0027	CcSEcCtD
Estropipate—Anaphylactic shock—Irinotecan—colon cancer	0.000646	0.0027	CcSEcCtD
Estropipate—Myalgia—Fluorouracil—colon cancer	0.000646	0.0027	CcSEcCtD
Estropipate—Infection—Irinotecan—colon cancer	0.000642	0.00268	CcSEcCtD
Estropipate—Hepatobiliary disease—Capecitabine—colon cancer	0.000642	0.00268	CcSEcCtD
Estropipate—Nervous system disorder—Irinotecan—colon cancer	0.000634	0.00265	CcSEcCtD
Estropipate—Irritability—Methotrexate—colon cancer	0.000625	0.00261	CcSEcCtD
Estropipate—Mood swings—Methotrexate—colon cancer	0.000621	0.00259	CcSEcCtD
Estropipate—Anaphylactic shock—Fluorouracil—colon cancer	0.000619	0.00259	CcSEcCtD
Estropipate—Oedema—Fluorouracil—colon cancer	0.000619	0.00259	CcSEcCtD
Estropipate—Infection—Fluorouracil—colon cancer	0.000615	0.00257	CcSEcCtD
Estropipate—Rhinitis—Capecitabine—colon cancer	0.00061	0.00255	CcSEcCtD
Estropipate—Nervous system disorder—Fluorouracil—colon cancer	0.000607	0.00254	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000605	0.00253	CcSEcCtD
Estropipate—Pharyngitis—Capecitabine—colon cancer	0.000604	0.00252	CcSEcCtD
Estropipate—Insomnia—Vincristine—colon cancer	0.0006	0.00251	CcSEcCtD
Estropipate—Oedema peripheral—Capecitabine—colon cancer	0.0006	0.00251	CcSEcCtD
Estropipate—Paraesthesia—Vincristine—colon cancer	0.000596	0.00249	CcSEcCtD
Estropipate—Breast disorder—Methotrexate—colon cancer	0.000592	0.00247	CcSEcCtD
Estropipate—Visual impairment—Capecitabine—colon cancer	0.000587	0.00245	CcSEcCtD
Estropipate—Insomnia—Irinotecan—colon cancer	0.000585	0.00244	CcSEcCtD
Estropipate—Conjugated Estrogens—ABCB1—colon cancer	0.000582	0.126	CrCbGaD
Estropipate—Estrone—ABCB1—colon cancer	0.000581	0.126	CrCbGaD
Estropipate—Paraesthesia—Irinotecan—colon cancer	0.00058	0.00242	CcSEcCtD
Estropipate—Erythema multiforme—Capecitabine—colon cancer	0.000576	0.00241	CcSEcCtD
Estropipate—Somnolence—Irinotecan—colon cancer	0.000575	0.0024	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vincristine—colon cancer	0.000573	0.00239	CcSEcCtD
Estropipate—CYP3A4—liver—colon cancer	0.000573	0.0102	CbGeAlD
Estropipate—Fatigue—Vincristine—colon cancer	0.000572	0.00239	CcSEcCtD
Estropipate—Eye disorder—Capecitabine—colon cancer	0.000569	0.00238	CcSEcCtD
Estropipate—Dyspepsia—Irinotecan—colon cancer	0.000569	0.00238	CcSEcCtD
Estropipate—Pain—Vincristine—colon cancer	0.000568	0.00237	CcSEcCtD
Estropipate—Constipation—Vincristine—colon cancer	0.000568	0.00237	CcSEcCtD
Estropipate—Asthma—Methotrexate—colon cancer	0.000566	0.00237	CcSEcCtD
Estropipate—Cardiac disorder—Capecitabine—colon cancer	0.000565	0.00236	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000564	0.00236	CcSEcCtD
Estropipate—Insomnia—Fluorouracil—colon cancer	0.00056	0.00234	CcSEcCtD
Estropipate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000558	0.00233	CcSEcCtD
Estropipate—Fatigue—Irinotecan—colon cancer	0.000557	0.00233	CcSEcCtD
Estropipate—Paraesthesia—Fluorouracil—colon cancer	0.000556	0.00232	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—colon cancer	0.000555	0.00232	CcSEcCtD
Estropipate—Pain—Irinotecan—colon cancer	0.000553	0.00231	CcSEcCtD
Estropipate—Constipation—Irinotecan—colon cancer	0.000553	0.00231	CcSEcCtD
Estropipate—Angiopathy—Capecitabine—colon cancer	0.000552	0.00231	CcSEcCtD
Estropipate—Somnolence—Fluorouracil—colon cancer	0.00055	0.0023	CcSEcCtD
Estropipate—Immune system disorder—Capecitabine—colon cancer	0.00055	0.0023	CcSEcCtD
Estropipate—Mediastinal disorder—Capecitabine—colon cancer	0.000549	0.00229	CcSEcCtD
Estropipate—Dyspepsia—Fluorouracil—colon cancer	0.000545	0.00228	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—colon cancer	0.000543	0.00227	CcSEcCtD
Estropipate—Gastrointestinal pain—Vincristine—colon cancer	0.000543	0.00227	CcSEcCtD
Estropipate—Alopecia—Capecitabine—colon cancer	0.000538	0.00225	CcSEcCtD
Estropipate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000534	0.00223	CcSEcCtD
Estropipate—Mental disorder—Capecitabine—colon cancer	0.000533	0.00223	CcSEcCtD
Estropipate—Erythema—Capecitabine—colon cancer	0.00053	0.00221	CcSEcCtD
Estropipate—Malnutrition—Capecitabine—colon cancer	0.00053	0.00221	CcSEcCtD
Estropipate—Dysuria—Methotrexate—colon cancer	0.00053	0.00221	CcSEcCtD
Estropipate—Pain—Fluorouracil—colon cancer	0.000529	0.00221	CcSEcCtD
Estropipate—Gastrointestinal pain—Irinotecan—colon cancer	0.000529	0.00221	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000526	0.0022	CcSEcCtD
Estropipate—Abdominal pain—Vincristine—colon cancer	0.000525	0.00219	CcSEcCtD
Estropipate—Body temperature increased—Vincristine—colon cancer	0.000525	0.00219	CcSEcCtD
Estropipate—Flatulence—Capecitabine—colon cancer	0.000522	0.00218	CcSEcCtD
Estropipate—Back pain—Capecitabine—colon cancer	0.000513	0.00214	CcSEcCtD
Estropipate—Abdominal pain—Irinotecan—colon cancer	0.000511	0.00213	CcSEcCtD
Estropipate—Body temperature increased—Irinotecan—colon cancer	0.000511	0.00213	CcSEcCtD
Estropipate—Muscle spasms—Capecitabine—colon cancer	0.00051	0.00213	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—colon cancer	0.000505	0.00211	CcSEcCtD
Estropipate—Infestation—Methotrexate—colon cancer	0.000505	0.00211	CcSEcCtD
Estropipate—Depression—Methotrexate—colon cancer	0.000503	0.0021	CcSEcCtD
Estropipate—Urticaria—Fluorouracil—colon cancer	0.000492	0.00205	CcSEcCtD
Estropipate—Body temperature increased—Fluorouracil—colon cancer	0.000489	0.00204	CcSEcCtD
Estropipate—Hypersensitivity—Vincristine—colon cancer	0.000489	0.00204	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—colon cancer	0.000478	0.002	CcSEcCtD
Estropipate—Vertigo—Capecitabine—colon cancer	0.000476	0.00199	CcSEcCtD
Estropipate—Hypersensitivity—Irinotecan—colon cancer	0.000476	0.00199	CcSEcCtD
Estropipate—Asthenia—Vincristine—colon cancer	0.000476	0.00199	CcSEcCtD
Estropipate—Palpitations—Capecitabine—colon cancer	0.000468	0.00196	CcSEcCtD
Estropipate—Asthenia—Irinotecan—colon cancer	0.000464	0.00194	CcSEcCtD
Estropipate—Cough—Capecitabine—colon cancer	0.000463	0.00193	CcSEcCtD
Estropipate—Hypersensitivity—Fluorouracil—colon cancer	0.000456	0.00191	CcSEcCtD
Estropipate—Diarrhoea—Vincristine—colon cancer	0.000454	0.0019	CcSEcCtD
Estropipate—Myalgia—Capecitabine—colon cancer	0.000451	0.00189	CcSEcCtD
Estropipate—Arthralgia—Capecitabine—colon cancer	0.000451	0.00189	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—colon cancer	0.00045	0.00188	CcSEcCtD
Estropipate—Anxiety—Capecitabine—colon cancer	0.00045	0.00188	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000448	0.00187	CcSEcCtD
Estropipate—Diarrhoea—Irinotecan—colon cancer	0.000442	0.00185	CcSEcCtD
Estropipate—Estradiol—ABCB1—colon cancer	0.00044	0.0952	CrCbGaD
Estropipate—Dizziness—Vincristine—colon cancer	0.000439	0.00183	CcSEcCtD
Estropipate—Pruritus—Fluorouracil—colon cancer	0.000438	0.00183	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—colon cancer	0.000437	0.00183	CcSEcCtD
Estropipate—Oedema—Capecitabine—colon cancer	0.000433	0.00181	CcSEcCtD
Estropipate—Infection—Capecitabine—colon cancer	0.00043	0.0018	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—colon cancer	0.000429	0.00179	CcSEcCtD
Estropipate—Dizziness—Irinotecan—colon cancer	0.000427	0.00179	CcSEcCtD
Estropipate—Nervous system disorder—Capecitabine—colon cancer	0.000424	0.00177	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—colon cancer	0.000424	0.00177	CcSEcCtD
Estropipate—Diarrhoea—Fluorouracil—colon cancer	0.000424	0.00177	CcSEcCtD
Estropipate—Vomiting—Vincristine—colon cancer	0.000422	0.00176	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—colon cancer	0.000421	0.00176	CcSEcCtD
Estropipate—Skin disorder—Capecitabine—colon cancer	0.00042	0.00176	CcSEcCtD
Estropipate—Rash—Vincristine—colon cancer	0.000418	0.00175	CcSEcCtD
Estropipate—Dermatitis—Vincristine—colon cancer	0.000418	0.00175	CcSEcCtD
Estropipate—Headache—Vincristine—colon cancer	0.000416	0.00174	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—colon cancer	0.000411	0.00172	CcSEcCtD
Estropipate—Vomiting—Irinotecan—colon cancer	0.000411	0.00172	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—colon cancer	0.000409	0.00171	CcSEcCtD
Estropipate—Dizziness—Fluorouracil—colon cancer	0.000409	0.00171	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—colon cancer	0.000409	0.00171	CcSEcCtD
Estropipate—Rash—Irinotecan—colon cancer	0.000408	0.0017	CcSEcCtD
Estropipate—Dermatitis—Irinotecan—colon cancer	0.000407	0.0017	CcSEcCtD
Estropipate—Headache—Irinotecan—colon cancer	0.000405	0.00169	CcSEcCtD
Estropipate—Alopecia—Methotrexate—colon cancer	0.000401	0.00167	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—colon cancer	0.000397	0.00166	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—colon cancer	0.000395	0.00165	CcSEcCtD
Estropipate—Erythema—Methotrexate—colon cancer	0.000395	0.00165	CcSEcCtD
Estropipate—Nausea—Vincristine—colon cancer	0.000394	0.00165	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000394	0.00165	CcSEcCtD
Estropipate—Vomiting—Fluorouracil—colon cancer	0.000394	0.00164	CcSEcCtD
Estropipate—Insomnia—Capecitabine—colon cancer	0.000391	0.00163	CcSEcCtD
Estropipate—Rash—Fluorouracil—colon cancer	0.00039	0.00163	CcSEcCtD
Estropipate—Dermatitis—Fluorouracil—colon cancer	0.00039	0.00163	CcSEcCtD
Estropipate—Paraesthesia—Capecitabine—colon cancer	0.000388	0.00162	CcSEcCtD
Estropipate—Headache—Fluorouracil—colon cancer	0.000388	0.00162	CcSEcCtD
Estropipate—Nausea—Irinotecan—colon cancer	0.000384	0.0016	CcSEcCtD
Estropipate—Back pain—Methotrexate—colon cancer	0.000382	0.00159	CcSEcCtD
Estropipate—Dyspepsia—Capecitabine—colon cancer	0.000381	0.00159	CcSEcCtD
Estropipate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000373	0.00156	CcSEcCtD
Estropipate—Fatigue—Capecitabine—colon cancer	0.000373	0.00156	CcSEcCtD
Estropipate—Pain—Capecitabine—colon cancer	0.00037	0.00155	CcSEcCtD
Estropipate—Constipation—Capecitabine—colon cancer	0.00037	0.00155	CcSEcCtD
Estropipate—Nausea—Fluorouracil—colon cancer	0.000368	0.00154	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.000355	0.00382	CbGpPWpGaD
Estropipate—Vertigo—Methotrexate—colon cancer	0.000355	0.00148	CcSEcCtD
Estropipate—Gastrointestinal pain—Capecitabine—colon cancer	0.000354	0.00148	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000348	0.00375	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000347	0.00373	CbGpPWpGaD
Estropipate—Cough—Methotrexate—colon cancer	0.000344	0.00144	CcSEcCtD
Estropipate—Urticaria—Capecitabine—colon cancer	0.000344	0.00144	CcSEcCtD
Estropipate—Body temperature increased—Capecitabine—colon cancer	0.000342	0.00143	CcSEcCtD
Estropipate—Abdominal pain—Capecitabine—colon cancer	0.000342	0.00143	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000337	0.00363	CbGpPWpGaD
Estropipate—Myalgia—Methotrexate—colon cancer	0.000336	0.0014	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—colon cancer	0.000336	0.0014	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000334	0.00139	CcSEcCtD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000333	0.00359	CbGpPWpGaD
Estropipate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000332	0.00357	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000328	0.00353	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—MYC—colon cancer	0.000325	0.00349	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000324	0.00349	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000323	0.00347	CbGpPWpGaD
Estropipate—Anaphylactic shock—Methotrexate—colon cancer	0.000322	0.00135	CcSEcCtD
Estropipate—Infection—Methotrexate—colon cancer	0.00032	0.00134	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—MYC—colon cancer	0.000319	0.00343	CbGpPWpGaD
Estropipate—Hypersensitivity—Capecitabine—colon cancer	0.000319	0.00133	CcSEcCtD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000316	0.0034	CbGpPWpGaD
Estropipate—Nervous system disorder—Methotrexate—colon cancer	0.000316	0.00132	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—colon cancer	0.000313	0.00131	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000312	0.00336	CbGpPWpGaD
Estropipate—Asthenia—Capecitabine—colon cancer	0.00031	0.0013	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000309	0.00332	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—CCND1—colon cancer	0.000309	0.00332	CbGpPWpGaD
Estropipate—Pruritus—Capecitabine—colon cancer	0.000306	0.00128	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000306	0.00329	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000304	0.00327	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000302	0.00325	CbGpPWpGaD
Estropipate—Diarrhoea—Capecitabine—colon cancer	0.000296	0.00124	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000295	0.00318	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000293	0.00123	CcSEcCtD
Estropipate—Insomnia—Methotrexate—colon cancer	0.000291	0.00122	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—colon cancer	0.000289	0.00121	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000289	0.00311	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000289	0.00311	CbGpPWpGaD
Estropipate—Somnolence—Methotrexate—colon cancer	0.000286	0.0012	CcSEcCtD
Estropipate—Dizziness—Capecitabine—colon cancer	0.000286	0.0012	CcSEcCtD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000285	0.00307	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—EP300—colon cancer	0.000284	0.00305	CbGpPWpGaD
Estropipate—Dyspepsia—Methotrexate—colon cancer	0.000283	0.00118	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000281	0.00302	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000279	0.003	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000278	0.00299	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000278	0.00299	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000278	0.00116	CcSEcCtD
Estropipate—Fatigue—Methotrexate—colon cancer	0.000278	0.00116	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—CCND1—colon cancer	0.000275	0.00296	CbGpPWpGaD
Estropipate—Pain—Methotrexate—colon cancer	0.000275	0.00115	CcSEcCtD
Estropipate—Vomiting—Capecitabine—colon cancer	0.000275	0.00115	CcSEcCtD
Estropipate—Rash—Capecitabine—colon cancer	0.000273	0.00114	CcSEcCtD
Estropipate—Dermatitis—Capecitabine—colon cancer	0.000273	0.00114	CcSEcCtD
Estropipate—Headache—Capecitabine—colon cancer	0.000271	0.00113	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CCND1—colon cancer	0.000269	0.00289	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000266	0.00287	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000266	0.00286	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000265	0.00285	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Methotrexate—colon cancer	0.000263	0.0011	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—TP53—colon cancer	0.000262	0.00282	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.00026	0.0028	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—EP300—colon cancer	0.000259	0.00278	CbGpPWpGaD
Estropipate—Nausea—Capecitabine—colon cancer	0.000257	0.00107	CcSEcCtD
Estropipate—Urticaria—Methotrexate—colon cancer	0.000256	0.00107	CcSEcCtD
Estropipate—SLC22A1—Metabolism—CA7—colon cancer	0.000256	0.00275	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—CCND1—colon cancer	0.000255	0.00274	CbGpPWpGaD
Estropipate—Abdominal pain—Methotrexate—colon cancer	0.000255	0.00106	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—colon cancer	0.000255	0.00106	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—EP300—colon cancer	0.000248	0.00266	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000246	0.00264	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000245	0.00264	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000244	0.00262	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000239	0.00258	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000239	0.00257	CbGpPWpGaD
Estropipate—Hypersensitivity—Methotrexate—colon cancer	0.000237	0.000991	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000237	0.00255	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000237	0.00255	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000232	0.00249	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000232	0.00249	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000231	0.00249	CbGpPWpGaD
Estropipate—Asthenia—Methotrexate—colon cancer	0.000231	0.000965	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000231	0.00248	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—FGFR3—colon cancer	0.00023	0.00247	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.00023	0.00247	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—SRC—colon cancer	0.000228	0.00245	CbGpPWpGaD
Estropipate—Pruritus—Methotrexate—colon cancer	0.000228	0.000952	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—MYC—colon cancer	0.000221	0.00238	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.00022	0.00237	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—TGFB1—colon cancer	0.00022	0.00237	CbGpPWpGaD
Estropipate—Diarrhoea—Methotrexate—colon cancer	0.00022	0.000921	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.00022	0.00237	CbGpPWpGaD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00022	0.00237	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—EGFR—colon cancer	0.000216	0.00232	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MYC—colon cancer	0.000216	0.00232	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	0.000215	0.00232	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000214	0.0023	CbGpPWpGaD
Estropipate—Dizziness—Methotrexate—colon cancer	0.000213	0.00089	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000208	0.00224	CbGpPWpGaD
Estropipate—Vomiting—Methotrexate—colon cancer	0.000205	0.000855	CcSEcCtD
Estropipate—Rash—Methotrexate—colon cancer	0.000203	0.000848	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—colon cancer	0.000203	0.000848	CcSEcCtD
Estropipate—Headache—Methotrexate—colon cancer	0.000202	0.000843	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000199	0.00214	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000195	0.0021	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	0.000194	0.00209	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	0.000193	0.00207	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000192	0.00207	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000192	0.00206	CbGpPWpGaD
Estropipate—Nausea—Methotrexate—colon cancer	0.000191	0.000799	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000191	0.00206	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000188	0.00202	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—HNF4A—colon cancer	0.000185	0.00199	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—colon cancer	0.000177	0.00191	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000177	0.00191	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000176	0.00189	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000176	0.00189	CbGpPWpGaD
Estropipate—ALB—Metabolism—CA7—colon cancer	0.000171	0.00184	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—PPARG—colon cancer	0.000167	0.0018	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	0.000165	0.00177	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000163	0.00175	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—HRAS—colon cancer	0.00016	0.00173	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000157	0.00169	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ODC1—colon cancer	0.000155	0.00167	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CHST5—colon cancer	0.000155	0.00167	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000154	0.00165	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—AKT1—colon cancer	0.000153	0.00165	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—DLC1—colon cancer	0.000153	0.00164	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	0.00015	0.00161	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000149	0.00161	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000146	0.00157	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000146	0.00157	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000145	0.00156	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000144	0.00155	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	0.000144	0.00155	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—LGR5—colon cancer	0.000143	0.00154	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000142	0.00153	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000142	0.00153	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—AKT1—colon cancer	0.000142	0.00152	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	0.00014	0.00151	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CA7—colon cancer	0.00014	0.00151	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000139	0.00149	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000137	0.00147	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000134	0.00144	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000133	0.00144	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000133	0.00143	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000133	0.00143	CbGpPWpGaD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000131	0.00141	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000128	0.00137	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—colon cancer	0.000127	0.00137	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000127	0.00137	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000127	0.00136	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000125	0.00134	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000125	0.00134	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRAS—colon cancer	0.000125	0.00134	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000124	0.00133	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000121	0.0013	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000121	0.0013	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CA7—colon cancer	0.00012	0.00129	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000119	0.00128	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000118	0.00127	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—TGFB1—colon cancer	0.000117	0.00126	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000117	0.00126	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000117	0.00125	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000114	0.00123	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—colon cancer	0.000114	0.00122	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—colon cancer	0.000112	0.00121	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000111	0.0012	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000111	0.00119	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—BRAF—colon cancer	0.00011	0.00118	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000108	0.00116	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000108	0.00116	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—colon cancer	0.000107	0.00115	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000105	0.00113	CbGpPWpGaD
Estropipate—ALB—Metabolism—ODC1—colon cancer	0.000104	0.00111	CbGpPWpGaD
Estropipate—ALB—Metabolism—CHST5—colon cancer	0.000104	0.00111	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AXIN2—colon cancer	0.000103	0.00111	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.0001	0.00108	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	9.85e-05	0.00106	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.67e-05	0.00104	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.65e-05	0.00104	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	9.58e-05	0.00103	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—colon cancer	9.53e-05	0.00102	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.46e-05	0.00102	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—HNF4A—colon cancer	9.34e-05	0.001	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CA7—colon cancer	9.23e-05	0.000993	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—colon cancer	9.12e-05	0.000981	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.93e-05	0.000961	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	8.74e-05	0.00094	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ODC1—colon cancer	8.48e-05	0.000912	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CHST5—colon cancer	8.48e-05	0.000912	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—PPARG—colon cancer	8.42e-05	0.000906	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.21e-05	0.000883	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	8.09e-05	0.00087	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—colon cancer	8.05e-05	0.000866	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PPARG—colon cancer	8.04e-05	0.000865	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.94e-05	0.000854	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ODC1—colon cancer	7.25e-05	0.000779	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CHST5—colon cancer	7.25e-05	0.000779	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.71e-05	0.000721	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	6.61e-05	0.000711	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	5.84e-05	0.000629	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	5.8e-05	0.000624	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	5.65e-05	0.000607	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ODC1—colon cancer	5.59e-05	0.000602	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CHST5—colon cancer	5.59e-05	0.000602	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	5.18e-05	0.000558	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—colon cancer	5.06e-05	0.000545	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—colon cancer	4.8e-05	0.000517	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—colon cancer	4.59e-05	0.000493	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	4.41e-05	0.000474	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.28e-05	0.00046	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ABCB1—colon cancer	4.09e-05	0.00044	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—colon cancer	4.06e-05	0.000436	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TYMS—colon cancer	4.02e-05	0.000432	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.6e-05	0.000388	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.5e-05	0.000377	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.36e-05	0.000362	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—colon cancer	3.18e-05	0.000342	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—colon cancer	3.07e-05	0.000331	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.99e-05	0.000322	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—colon cancer	2.99e-05	0.000321	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGFR3—colon cancer	2.98e-05	0.00032	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—colon cancer	2.91e-05	0.000313	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—colon cancer	2.88e-05	0.000309	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—colon cancer	2.85e-05	0.000306	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.8e-05	0.000301	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.75e-05	0.000296	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—colon cancer	2.74e-05	0.000294	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—colon cancer	2.73e-05	0.000294	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—colon cancer	2.69e-05	0.000289	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—colon cancer	2.67e-05	0.000287	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—colon cancer	2.57e-05	0.000276	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—colon cancer	2.47e-05	0.000266	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.35e-05	0.000253	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—colon cancer	2.31e-05	0.000249	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.29e-05	0.000246	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—colon cancer	2.27e-05	0.000245	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—colon cancer	2.24e-05	0.000241	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—colon cancer	2.24e-05	0.000241	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—colon cancer	2.2e-05	0.000237	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—colon cancer	2.2e-05	0.000237	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—colon cancer	2.1e-05	0.000226	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.07e-05	0.000223	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.96e-05	0.000211	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—colon cancer	1.93e-05	0.000207	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—colon cancer	1.91e-05	0.000206	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—colon cancer	1.9e-05	0.000205	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—colon cancer	1.88e-05	0.000202	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—colon cancer	1.87e-05	0.000202	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—colon cancer	1.86e-05	0.0002	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—colon cancer	1.86e-05	0.0002	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—colon cancer	1.86e-05	0.0002	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—colon cancer	1.81e-05	0.000195	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—colon cancer	1.73e-05	0.000186	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.69e-05	0.000182	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—colon cancer	1.68e-05	0.00018	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—colon cancer	1.63e-05	0.000176	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—colon cancer	1.61e-05	0.000174	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—colon cancer	1.6e-05	0.000173	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—colon cancer	1.56e-05	0.000168	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—colon cancer	1.5e-05	0.000162	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—colon cancer	1.5e-05	0.000161	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—colon cancer	1.5e-05	0.000161	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—colon cancer	1.48e-05	0.000159	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—colon cancer	1.47e-05	0.000158	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—colon cancer	1.45e-05	0.000156	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.45e-05	0.000156	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—colon cancer	1.39e-05	0.000149	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—colon cancer	1.38e-05	0.000148	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—colon cancer	1.33e-05	0.000143	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—colon cancer	1.28e-05	0.000137	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—colon cancer	1.25e-05	0.000134	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—colon cancer	1.23e-05	0.000133	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—colon cancer	1.23e-05	0.000132	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—colon cancer	1.18e-05	0.000127	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—colon cancer	1.13e-05	0.000121	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—colon cancer	1.05e-05	0.000113	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—colon cancer	1.04e-05	0.000112	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—colon cancer	1.03e-05	0.000111	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—colon cancer	1.02e-05	0.00011	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—colon cancer	9.22e-06	9.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—colon cancer	8.72e-06	9.38e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—colon cancer	8.09e-06	8.7e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—colon cancer	7.54e-06	8.12e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—colon cancer	7.53e-06	8.1e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—colon cancer	6.73e-06	7.24e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—colon cancer	6.45e-06	6.94e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—colon cancer	6.16e-06	6.63e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—colon cancer	5.27e-06	5.67e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—colon cancer	4.98e-06	5.35e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—colon cancer	4.06e-06	4.37e-05	CbGpPWpGaD
